ATE406437T1 - Methode zur identifikation antifungischer moleküle, welche auf die glukanosyltransferaseaktivität wirken - Google Patents

Methode zur identifikation antifungischer moleküle, welche auf die glukanosyltransferaseaktivität wirken

Info

Publication number
ATE406437T1
ATE406437T1 AT97938964T AT97938964T ATE406437T1 AT E406437 T1 ATE406437 T1 AT E406437T1 AT 97938964 T AT97938964 T AT 97938964T AT 97938964 T AT97938964 T AT 97938964T AT E406437 T1 ATE406437 T1 AT E406437T1
Authority
AT
Austria
Prior art keywords
antifungic
identifying
transferase activity
molecules acting
glucanosyl
Prior art date
Application number
AT97938964T
Other languages
English (en)
Inventor
Thierry Fontaine
Robbert Hartland
Isabelle Mouyna
Jean-Paul Latge
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE406437T1 publication Critical patent/ATE406437T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18Testing for antimicrobial activity of a material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1048Glycosyltransferases (2.4)
    • C12N9/1051Hexosyltransferases (2.4.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01LSEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L28/00Passive two-terminal components without a potential-jump or surface barrier for integrated circuits; Details thereof; Multistep manufacturing processes therefor
    • H01L28/40Capacitors
    • H01L28/60Electrodes
    • H01L28/82Electrodes with an enlarged surface, e.g. formed by texturisation
    • H01L28/90Electrodes with an enlarged surface, e.g. formed by texturisation having vertical extensions
    • H01L28/92Electrodes with an enlarged surface, e.g. formed by texturisation having vertical extensions made by patterning layers, e.g. by etching conductive layers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/37Assays involving biological materials from specific organisms or of a specific nature from fungi
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/37Assays involving biological materials from specific organisms or of a specific nature from fungi
    • G01N2333/39Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/91Transferases (2.)
    • G01N2333/91091Glycosyltransferases (2.4)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/91Transferases (2.)
    • G01N2333/91091Glycosyltransferases (2.4)
    • G01N2333/91097Hexosyltransferases (general) (2.4.1)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/04Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10BELECTRONIC MEMORY DEVICES
    • H10B12/00Dynamic random access memory [DRAM] devices
    • H10B12/01Manufacture or treatment
    • H10B12/02Manufacture or treatment for one transistor one-capacitor [1T-1C] memory cells
    • H10B12/03Making the capacitor or connections thereto
    • H10B12/033Making the capacitor or connections thereto the capacitor extending over the transistor

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Power Engineering (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Computer Hardware Design (AREA)
  • Biomedical Technology (AREA)
  • Microelectronics & Electronic Packaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
AT97938964T 1996-08-30 1997-08-29 Methode zur identifikation antifungischer moleküle, welche auf die glukanosyltransferaseaktivität wirken ATE406437T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2491096P 1996-08-30 1996-08-30

Publications (1)

Publication Number Publication Date
ATE406437T1 true ATE406437T1 (de) 2008-09-15

Family

ID=21822985

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97938964T ATE406437T1 (de) 1996-08-30 1997-08-29 Methode zur identifikation antifungischer moleküle, welche auf die glukanosyltransferaseaktivität wirken

Country Status (8)

Country Link
US (5) US6551811B1 (de)
EP (1) EP0932665B1 (de)
JP (1) JP2001501814A (de)
AT (1) ATE406437T1 (de)
AU (1) AU4121997A (de)
DE (1) DE69738945D1 (de)
ES (1) ES2312178T3 (de)
WO (1) WO1998008937A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0932665B1 (de) * 1996-08-30 2008-08-27 Institut Pasteur Methode zur identifikation antifungischer moleküle, welche auf die glukanosyltransferaseaktivität wirken
US7508206B2 (en) * 2002-05-20 2009-03-24 Massachusetts Institute Of Technology Method for sequence determination using NMR
KR102144998B1 (ko) * 2013-08-30 2020-08-14 삼성전자주식회사 효모에 내산성을 부여하는 폴리펩티드, 그를 코딩하는 폴리뉴클레오티드, 그 양이 증가되어 있는 효모 세포, 상기 효모 세포를 이용한 산물의 생산 방법 및 내산성 효모 세포를 생산하는 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0932665B1 (de) * 1996-08-30 2008-08-27 Institut Pasteur Methode zur identifikation antifungischer moleküle, welche auf die glukanosyltransferaseaktivität wirken

Also Published As

Publication number Publication date
US5989895A (en) 1999-11-23
AU4121997A (en) 1998-03-19
WO1998008937A1 (fr) 1998-03-05
EP0932665B1 (de) 2008-08-27
US20030152986A1 (en) 2003-08-14
ES2312178T3 (es) 2009-02-16
DE69738945D1 (de) 2008-10-09
JP2001501814A (ja) 2001-02-13
EP0932665A1 (de) 1999-08-04
US20030147856A1 (en) 2003-08-07
US7060454B2 (en) 2006-06-13
US7022495B2 (en) 2006-04-04
US6551811B1 (en) 2003-04-22
US20060211013A1 (en) 2006-09-21

Similar Documents

Publication Publication Date Title
ATE408422T1 (de) Methode zur hemmung immunstimulatorischer mit dna assoziierter antworten
DE69023120D1 (de) Infusionssystem, methodologie und algorithmus zur identifizierung von patienten-induzierten druckartefakten.
DE69918089D1 (de) Btk inhibitoren und verfahren zur identifizierung und verwendung
WO1999036550A3 (en) Human protease molecules
ES8702431A1 (es) Procedimiento para preparar una proteina inhibidora de la coagulacion de la sangre
FI965031A (fi) Sieni, jossa AreA-geeni on muunnettu, ja Aspergillus oryzaesta peräisin oleva areA-geeni
DE69434614D1 (de) Cdn apoptosis modulierende proteine, sie kodierende dns und verfahren zu ihrer verwendung
DE3587989D1 (de) Vorrichtung zur Trennung der Proteine vom Blutplasma.
FI885504A0 (fi) Vaskulaera antikoagulerande proteiner, dessa koderande dna, deras framstaellningsfoerfarande och deras anvaendning.
ATE354661T1 (de) Nukleinsäuresequenzen und expressionssysteme für heparinase ii aus flavobacterium heparinum
ATE226254T1 (de) Reagenz zur behandlung von arthritischen zustaenden
DE69532033D1 (de) Für ein fibroblasten-aktivierungsprotein kodierende nukleinsäure und verwendungen dafür
DE58904259D1 (de) Verfahren zur hydrierung von alfa, beta-ungesaettigten ketonen.
HK1011560A1 (en) Method of diagnosing and treating epithelioma
BR9710919A (pt) Proteina purificada sr-p70
DE68917154D1 (de) C-terminus-amidierungsenzym-zusammensetzung, verfahren zur herstellung und verwendung.
ATE406437T1 (de) Methode zur identifikation antifungischer moleküle, welche auf die glukanosyltransferaseaktivität wirken
DE68914596D1 (de) Methode zur Gas-Flüssig-Kontaktierung.
DK0929299T3 (da) Substituerede 1,2,3,4-tetrahydro-2-dibenzofuranaminer og 2-aminocyclohepta-(b)benzofuraner
DE69840928D1 (de) Nachweismethoden für reagenzien, die das "inhibitor-der-apoptose-protein" (iap) regulieren und dadurch auf die caspaseaktivität einwirken
ATE312914T1 (de) Rdgb-proteine
DE69943184D1 (de) Identifizierung und funktionelle charakterisierung einer ribosomalen s6 proteinkinase
NZ334744A (en) Method for determining expression of aberrant forms of APC protein
PT1123396E (pt) Promotores minimos e seus usos
DK43393D0 (da) Dna-sekvens, der koder for et enzym

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties